80 related articles for article (PubMed ID: 3492270)
21. Proteinase inhibitors in rat serum. Purification and partial characterization of three functionally distinct trypsin inhibitors.
Kuehn L; Rutschmann M; Dahlmann B; Reinauer H
Biochem J; 1984 Mar; 218(3):953-9. PubMed ID: 6609702
[TBL] [Abstract][Full Text] [Related]
22. Serum proteolytic activities and antiproteases in human colorectal carcinoma.
Amiguet JA; Jiménez J; Monreal JI; Hernández MJ; López-Vivanco G; Vidán JR; Conchillo F; Liso P
J Physiol Biochem; 1998 Mar; 54(1):9-13. PubMed ID: 9732103
[TBL] [Abstract][Full Text] [Related]
23. Fetal-specific forms of alpha 1-protease inhibitors in mouse plasma.
Nathoo SA; Finlay TH
Pediatr Res; 1987 Jul; 22(1):1-5. PubMed ID: 2442697
[TBL] [Abstract][Full Text] [Related]
24. Expression screening of bacterial libraries of recombinant alpha-1 proteinase inhibitor variants for candidates with thrombin inhibitory capacity.
Bhakta V; Gierczak RF; Sheffield WP
J Biotechnol; 2013 Dec; 168(4):373-81. PubMed ID: 24140600
[TBL] [Abstract][Full Text] [Related]
25. Determination of oxidized alpha-1-proteinase inhibitor in serum.
Beatty K; Robertie P; Senior RM; Travis J
J Lab Clin Med; 1982 Aug; 100(2):186-92. PubMed ID: 6178785
[TBL] [Abstract][Full Text] [Related]
26. Fragmentation of a 70000-dalton calpastatin molecule upon its complex formation with calpain.
Shigeta K; Yumoto N; Murachi T
Biochem Int; 1984 Sep; 9(3):327-33. PubMed ID: 6095848
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of heparin and glucose on structural conformation of human alpha1 antitrypsin: evidence for a heparin-induced cleaved form of the inhibitor.
Finotti P; de Laureto PP
Arch Biochem Biophys; 1997 Nov; 347(1):19-29. PubMed ID: 9344460
[TBL] [Abstract][Full Text] [Related]
28. Low serum alpha-1-antitrypsin specific activity in monoclonal gammopathies.
Jelić-Ivanović Z; Stanković B; Topić A; Spasojević-Kalimanovska V; Spasić S
Panminerva Med; 2000 Mar; 42(1):17-21. PubMed ID: 11019599
[TBL] [Abstract][Full Text] [Related]
29. Serum immunoreactive trypsin and trypsin inhibitors during acute pancreatitis.
Mero M; Tenhunen R; Pessi T; Sandholm M
Ann Chir Gynaecol; 1980; 69(6):251-5. PubMed ID: 6163388
[TBL] [Abstract][Full Text] [Related]
30. A 33.5-kDa heat- and protease-resistant NADH oxidase inhibited by capsaicin from sera of cancer patients.
Chueh PJ; Morré DJ; Wilkinson FE; Gibson J; Morré DM
Arch Biochem Biophys; 1997 Jun; 342(1):38-47. PubMed ID: 9185612
[TBL] [Abstract][Full Text] [Related]
31. Trypsin inhibitory capacity in vernal keratoconjunctivitis.
Ghavami S; Hashemi M; de Serres FJ; Bajestani SN; Mehrabifar H; Leonardi A
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):264-9. PubMed ID: 17197542
[TBL] [Abstract][Full Text] [Related]
32. Serum trypsin inhibitory capacity in normal pregnancy and gestational diabetes mellitus.
Yaghmaei M; Hashemi M; Shikhzadeh A; Mokhtari M; Niazi A; Ghavami S
Diabetes Res Clin Pract; 2009 Jun; 84(3):201-4. PubMed ID: 19344972
[TBL] [Abstract][Full Text] [Related]
33. PFK inhibition test for cancer detection: clinical applications and mechanisms of PFK inhibition.
Nakamura K; Kituta T; Nakamura Y; Nakajima Y; Kobayashi K; Uchida T
Cancer Detect Prev; 1987; 10(1-2):37-55. PubMed ID: 2952272
[TBL] [Abstract][Full Text] [Related]
34. The absolute quantification of eight inter-α-trypsin inhibitor heavy chain 4 (ITIH4)-derived peptides in serum from breast cancer patients.
van den Broek I; Sparidans RW; van Winden AW; Gast MC; van Dulken EJ; Schellens JH; Beijnen JH
Proteomics Clin Appl; 2010 Dec; 4(12):931-9. PubMed ID: 21137033
[TBL] [Abstract][Full Text] [Related]
35. [Comparison of the antitrypsin activity levels in serum of normal subjects and cancer patients].
Gonzalez-Garza MT; Pacheco-Cano MG; Romero-Villaseñor G
Arch Invest Med (Mex); 1977; 8(1):39-46. PubMed ID: 849095
[TBL] [Abstract][Full Text] [Related]
36. Glycoprotein-adsorption from cancer sera--influence on a mixed lymphocyte culture.
Richner J; Schuff-Werner P; Bätge R; Beyer JH; Nagel GA
J Clin Lab Immunol; 1985 Oct; 18(2):75-9. PubMed ID: 2934552
[TBL] [Abstract][Full Text] [Related]
37. Detection of a human serum DNA-binding protein associated with malignant disease.
Parsons RG; Aldenderfer PH; Kowal R
J Natl Cancer Inst; 1979 Jul; 63(1):43-7. PubMed ID: 221718
[TBL] [Abstract][Full Text] [Related]
38. Human cationic and anionic trypsins: differences of interaction with alpha 1-proteinase inhibitor.
Vercaigne-Marko D; Carrère J; Guy-Crotte O; Figarella C; Hayem A
Biol Chem Hoppe Seyler; 1989 Nov; 370(11):1163-71. PubMed ID: 2610933
[TBL] [Abstract][Full Text] [Related]
39. Smoking does not reduce the functional activity of serum alpha-1-proteinase inhibitor. An epidemiologic study of 719 healthy men.
Lellouch J; Claude JR; Martin JP; Orssaud G; Zaoui D; Bieth JG
Am Rev Respir Dis; 1985 Oct; 132(4):818-20. PubMed ID: 3931523
[TBL] [Abstract][Full Text] [Related]
40. [Studies on the heterogeneity of blood serum high-molecular fraction proteins in healthy people and patients with cancer].
Kostrzhevs'ka OG; Kolesnikova IM; Korotkoruchko VP; Grigor'eva TL
Ukr Biokhim Zh; 1977; 49(6):19-23. PubMed ID: 929705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
